Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Allena Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 30 | 29 | −1 |
| Shares | 20.4M | 21.6M | +1.26M (+6.2%) |
| Value | $28.3M | $28.1M | −$193.0K (−0.7%) |
New holders (3)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kestra Advisory Services, LLC | 73,000 | $95.0K | 0.00% |
| Citadel Advisors LLC | 47,630 | $62.0K | 0.00% |
| State Street Corp | 34,258 | $45.0K | 0.00% |
Sold out (4)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Two Sigma Advisers, LP | 137,900 | $192.0K |
| Two Sigma Investments, LP | 40,200 | $56.0K |
| HRT Financial LP | 22,382 | $31.0K |
| Barclays PLC | 9,019 | $13.0K |